Literature DB >> 8491185

Characterization of full-length neurofibromin: tubulin inhibits Ras GAP activity.

G Bollag1, F McCormick, R Clark.   

Abstract

Full-length neurofibromin is a GTPase activating protein (GAP) for the Ras proto-oncogene product. Regulation of neurofibromin activity therefore has important implications for cell growth. Neurofibromin co-purifies with tubulin when expressed in insect cells. The interaction between neurofibromin and tubulin is sensitive to the microtubule depolymerizing agent colchicine. Neurofibromin GAP activity is inhibited even at low concentrations of tubulin. However, maximal inhibition of GAP activity is only approximately 70%, suggesting that the neurofibromin-tubulin complex retains residual GAP activity. This decreased activity is reflected by a 4-fold decrease in its affinity for Ras. A truncated mutant of neurofibromin with reduced sensitivity to tubulin localizes some tubulin-binding determinants to an 80 residue segment immediately N-terminal to the GAP-related domain. Since tubulin is an abundant protein in eukaryotic cells, the tubulin-neurofibromin interaction may regulate the Ras signalling pathway.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8491185      PMCID: PMC413413          DOI: 10.1002/j.1460-2075.1993.tb05841.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  26 in total

1.  The effect of GTPase activating protein upon ras is inhibited by mitogenically responsive lipids.

Authors:  M H Tsai; C L Yu; F S Wei; D W Stacey
Journal:  Science       Date:  1989-01-27       Impact factor: 47.728

2.  Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins.

Authors:  D Bar-Sagi; J R Feramisco
Journal:  Science       Date:  1986-09-05       Impact factor: 47.728

3.  A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations.

Authors:  R M Cawthon; R Weiss; G F Xu; D Viskochil; M Culver; J Stevens; M Robertson; D Dunn; R Gesteland; P O'Connell
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

4.  Separation of tubulin from microtubule-associated proteins on phosphocellulose. Accompanying alterations in concentrations of buffer components.

Authors:  R C Williams; H W Detrich
Journal:  Biochemistry       Date:  1979-06-12       Impact factor: 3.162

5.  Reversible assembly purification of microtubules without assembly-promoting agents and further purification of tubulin, microtubule-associated proteins, and MAP fragments.

Authors:  R B Vallee
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

6.  Purification of brain microtubules and microtubule-associated protein 1 using taxol.

Authors:  R B Vallee
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

7.  Changes in the extent of microtubule assembly can regulate initiation of DNA synthesis.

Authors:  D H Carney; K L Crossin; R Ball; G M Fuller; T Albrecht; W C Thompson
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

8.  Tightly regulated tac promoter vectors useful for the expression of unfused and fused proteins in Escherichia coli.

Authors:  E Amann; B Ochs; K J Abel
Journal:  Gene       Date:  1988-09-30       Impact factor: 3.688

Review 9.  ras oncogenes in human cancer: a review.

Authors:  J L Bos
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

10.  p21ras. Heterogeneous localization in transformed cells.

Authors:  S E Myrdal; N Auersperg
Journal:  Exp Cell Res       Date:  1985-08       Impact factor: 3.905

View more
  29 in total

Review 1.  Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.

Authors:  Steven L Carroll
Journal:  Acta Neuropathol       Date:  2011-12-11       Impact factor: 17.088

2.  A novel bipartite phospholipid-binding module in the neurofibromatosis type 1 protein.

Authors:  Igor D'Angelo; Stefan Welti; Fabien Bonneau; Klaus Scheffzek
Journal:  EMBO Rep       Date:  2006-02       Impact factor: 8.807

3.  A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors.

Authors:  A J Cappione; B L French; G R Skuse
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

Review 4.  Ras-Specific GTPase-Activating Proteins-Structures, Mechanisms, and Interactions.

Authors:  Klaus Scheffzek; Giridhar Shivalingaiah
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

5.  SPRED proteins provide a NF-ty link to Ras suppression.

Authors:  Andrea I McClatchey; Karen Cichowski
Journal:  Genes Dev       Date:  2012-07-15       Impact factor: 11.361

Review 6.  Malignant Peripheral Nerve Sheath Tumors: From Epigenome to Bedside.

Authors:  Justin Korfhage; David B Lombard
Journal:  Mol Cancer Res       Date:  2019-04-25       Impact factor: 5.852

7.  HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.

Authors:  A Omrani; T van der Vaart; E Mientjes; G M van Woerden; M R Hojjati; K W Li; D H Gutmann; C N Levelt; A B Smit; A J Silva; S A Kushner; Y Elgersma
Journal:  Mol Psychiatry       Date:  2015-04-28       Impact factor: 15.992

8.  Tfs1p, a member of the PEBP family, inhibits the Ira2p but not the Ira1p Ras GTPase-activating protein in Saccharomyces cerevisiae.

Authors:  Hélène Chautard; Michel Jacquet; Françoise Schoentgen; Nicole Bureaud; Hélène Bénédetti
Journal:  Eukaryot Cell       Date:  2004-04

Review 9.  Molecular genetics of neurofibromatosis type 1 (NF1).

Authors:  M H Shen; P S Harper; M Upadhyaya
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

10.  Structural analysis of the GAP-related domain from neurofibromin and its implications.

Authors:  K Scheffzek; M R Ahmadian; L Wiesmüller; W Kabsch; P Stege; F Schmitz; A Wittinghofer
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.